- Home
- ZYXI vs PROK Comparison
ZYXI vs PROK Comparison
Compare ZYXI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- PROK
- Stock Information
- Founded
- ZYXI 1996
- PROK 2015
- Country
- ZYXI United States
- PROK United States
- Employees
- ZYXI N/A
- PROK N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZYXI Health Care
- PROK Health Care
- Exchange
- ZYXI Nasdaq
- PROK Nasdaq
- Market Cap
- ZYXI 72.3M
- PROK 85.5M
- IPO Year
- ZYXI N/A
- PROK N/A
- Fundamental
- Price
- ZYXI $2.68
- PROK $0.58
- Analyst Decision
- ZYXI Buy
- PROK Hold
- Analyst Count
- ZYXI 3
- PROK 3
- Target Price
- ZYXI $6.00
- PROK $3.50
- AVG Volume (30 Days)
- ZYXI 275.6K
- PROK 1.6M
- Earning Date
- ZYXI 07-24-2025
- PROK 08-08-2025
- Dividend Yield
- ZYXI N/A
- PROK N/A
- EPS Growth
- ZYXI N/A
- PROK N/A
- EPS
- ZYXI N/A
- PROK N/A
- Revenue
- ZYXI $172,401,000.00
- PROK $306,000.00
- Revenue This Year
- ZYXI N/A
- PROK $54.34
- Revenue Next Year
- ZYXI $19.55
- PROK N/A
- P/E Ratio
- ZYXI N/A
- PROK N/A
- Revenue Growth
- ZYXI N/A
- PROK N/A
- 52 Week Low
- ZYXI $1.66
- PROK $0.46
- 52 Week High
- ZYXI $10.62
- PROK $2.59
- Technical
- Relative Strength Index (RSI)
- ZYXI 56.72
- PROK 39.26
- Support Level
- ZYXI $2.30
- PROK $0.54
- Resistance Level
- ZYXI $2.82
- PROK $0.90
- Average True Range (ATR)
- ZYXI 0.18
- PROK 0.13
- MACD
- ZYXI 0.04
- PROK -0.02
- Stochastic Oscillator
- ZYXI 65.66
- PROK 9.55
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.